Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis

被引:22
|
作者
Laura Alberti, Maria [1 ]
Malet Ruiz, Jose Maria [1 ]
Eduardo Fernandez, Martin [1 ]
Fassola, Leandro [1 ]
Caro, Fabian [1 ]
Buendia Roldan, Ivette [2 ]
Paulin, Francisco [1 ]
机构
[1] Hosp Maria Ferrer Buenos Aires, Interstitial Lung Dis Clin, Buenos Aires, DF, Argentina
[2] Inst Nacl Enfermedades Resp INER Ismael Cosio Vil, Buenos Aires, DF, Argentina
来源
PULMONOLOGY | 2020年 / 26卷 / 01期
关键词
Chronic hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Extrinsic allergic alveolitis; Interstitial lung disease; INTERSTITIAL PNEUMONIA; CT FINDINGS; DIAGNOSIS; AZATHIOPRINE;
D O I
10.1016/j.pulmoe.2019.08.007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential diagnosis. The aim of our study is to compare survival and functional decline between these two entities. Methods: Survival and functional decline more than 10% in FVC were compared using Kaplan Meier (KM) method between patients with CHP and IPF. Cox proportional hazard analysis was used to identify independent predictors of survival and functional decline. Results: 146 patients were included, 54 with CHP and 92 with IPF. KM rate for 2 years survival was 0.71 (CI 95% 0,6-0,8) for CHP group and 0,83 (CI 95% 0,66 - 0,92) for IPF (p = 0,027). Nevertheless this difference disappeared using Cox proportional hazard analysis, the adjusted HR for survival among CHP patients was 0,53 (CI 95% 0,25-1,15) (p = 0,11). There was no difference in functional evolution between the two groups. KM rate for a decline more than or equal to 10% was 0,64 for CHP (CI 95% 0,43-0,79) and 0,78 for IPF (IC 95% 0,6-0,88) (p = 0,22). This observation did not change after using Cox proportional hazard analysis. Conclusions: Our study shows that both IPF and CHP are fibrosing interstitial diseases with a similar evolution and survival. It might be possible that therapeutic approach in patients with CHP should change in the light of these observations. (C) 2019 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 50 条
  • [1] Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
    Zhou, Yiyi
    Fang, Chen
    Sun, Qinying
    Dong, Yuchao
    FRONTIERS IN GENETICS, 2022, 13
  • [2] Survival and Lung Function Changes in Hypersensitivity Pneumonitis According to Radiological Phenotypes Compared With Idiopathic Pulmonary Fibrosis
    Julia-Serda, Gabriel
    Navarro-Esteva, Javier
    Doreste-Salgado, Laura
    Veliz-Flores, Ibrahim
    Pestana-Santana, Ruben
    Gonzalez-Martin, Jesus Maria
    Rodriguez-de Castro, Felipe
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [3] Pathogenesis of chronic hypersensitivity pneumonitis (HP) - differences and similarities to idiopathic pulmonary fibrosis (IPF)
    Wygrecka, M.
    Wujak, L.
    Markart, P.
    ALLERGOLOGIE, 2017, 40 (07) : 268 - 272
  • [4] Chronic Summer-type Hypersensitivity Pneumonitis: clinical similarities to idiopathic pulmonary fibrosis
    Inase, Naohiko
    Ohtani, Yoshio
    Usui, Yutaka
    Miyazaki, Yasunari
    Takemura, Tamiko
    Yoshizawa, Yasuyuki
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2007, 24 (02) : 141 - 147
  • [5] The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
    Invernizzi, Rachele
    Wu, Benjamin G.
    Barnett, Joseph
    Ghai, Poonam
    Kingston, Shaun
    Hewitt, Richard J.
    Feary, Johanna
    Li, Yonghua
    Chua, Felix
    Wu, Zhe
    Wells, Athol U.
    George, Peter M.
    Renzoni, Elisabetta A.
    Nicholson, Andrew G.
    Rice, Alexandra
    Devaraj, Anand
    Segal, Leopoldo N.
    Byrne, Adam J.
    Maher, Toby M.
    Lloyd, Clare M.
    Molyneaux, Philip L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (03) : 339 - 347
  • [6] Comorbidities and survival in patients with chronic hypersensitivity pneumonitis
    Waelscher, Julia
    Gross, Benjamin
    Morisset, Julie
    Johannson, Kerri A.
    Vasakova, Martina
    Bruhwyler, Jacques
    Kreuter, Michael
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [7] Radiographic Fibrosis Score Predicts Survival in Hypersensitivity Pneumonitis
    Mooney, Joshua J.
    Elicker, Brett M.
    Urbania, Thomas H.
    Agarwal, Misha R.
    Ryerson, Christopher J.
    Nguyen, Michelle Linh T.
    Woodruff, Prescott G.
    Jones, Kirk D.
    Collard, Harold R.
    King, Talmadge E., Jr.
    Koth, Laura L.
    CHEST, 2013, 144 (02) : 586 - 592
  • [8] Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia
    Takemura, Tamiko
    Akashi, Takumi
    Kamiya, Hiroyuki
    Ikushima, Soichiro
    Ando, Tsunehiro
    Oritsu, Masaru
    Sawahata, Michiru
    Ogura, Takashi
    HISTOPATHOLOGY, 2012, 61 (06) : 1026 - 1035
  • [9] Histopathologic Analysis of Sixteen Autopsy Cases of Chronic Hypersensitivity Pneumonitis and Comparison With Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia
    Akashi, Takumi
    Takemura, Tamiko
    Ando, Noboru
    Eishi, Yoshinobu
    Kitagawa, Masanobu
    Takizawa, Touichirou
    Koike, Morio
    Ohtani, Yoshio
    Miyazaki, Yasunari
    Inase, Naohiko
    Yoshizawa, Yasuyuki
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (03) : 405 - 415
  • [10] The Pathogenesis of Chronic Hypersensitivity Pneumonitis in Common With Idiopathic Pulmonary Fibrosis Expression of Apoptotic Markers
    Jinta, Torahiko
    Miyazaki, Yasunari
    Kishi, Masato
    Akashi, Takumi
    Takemura, Tamiko
    Inase, Naohiko
    Yoshizawa, Yasuyuki
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (04) : 613 - 620